Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 369 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA accepts Symplmed’s Prestalia NDA

Prestalia, which is the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate, is indicated for the treatment of hypertension in the U.S. Perindopril is a

Pfizer submits Meningococcal B Vaccine BLA

The bivalent rLP2086 vaccine is indicated for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25-year-olds. Pfizer vaccine research and development